Display options
Cite
Spek A, Li B, Rutz B, et al. Purinergic smooth muscle contractions in the human prostate: estimation of relevance and characterization of different agonists. Naunyn Schmiedebergs Arch Pharmacol. 2021;394(6):1113-1131doi: 10.1007/s00210-020-02044-4.
Spek, A., Li, B., Rutz, B., Ciotkowska, A., Huang, R., Liu, Y., Wang, R., Strittmatter, F., Waidelich, R., Stief, C. G., & Hennenberg, M. (2021). Purinergic smooth muscle contractions in the human prostate: estimation of relevance and characterization of different agonists. Naunyn-Schmiedeberg's archives of pharmacology, 394(6), 1113-1131. https://doi.org/10.1007/s00210-020-02044-4
Spek, Annabel, et al. "Purinergic smooth muscle contractions in the human prostate: estimation of relevance and characterization of different agonists." Naunyn-Schmiedeberg's archives of pharmacology vol. 394,6 (2021): 1113-1131. doi: https://doi.org/10.1007/s00210-020-02044-4
Spek A, Li B, Rutz B, Ciotkowska A, Huang R, Liu Y, Wang R, Strittmatter F, Waidelich R, Stief CG, Hennenberg M. Purinergic smooth muscle contractions in the human prostate: estimation of relevance and characterization of different agonists. Naunyn Schmiedebergs Arch Pharmacol. 2021 Jun;394(6):1113-1131. doi: 10.1007/s00210-020-02044-4. Epub 2021 Jan 11. PMID: 33427927; PMCID: PMC8208936.
Copy Download .nbib Format: NLM
Share it on

Naunyn Schmiedebergs Arch Pharmacol. 2021 Jun;394(6):1113-1131. doi: 10.1007/s00210-020-02044-4. Epub 2021 Jan 11.

Purinergic smooth muscle contractions in the human prostate: estimation of relevance and characterization of different agonists.

Naunyn-Schmiedeberg's archives of pharmacology

Annabel Spek, Bingsheng Li, Beata Rutz, Anna Ciotkowska, Ru Huang, Yuhan Liu, Ruixiao Wang, Frank Strittmatter, Raphaela Waidelich, Christian G Stief, Martin Hennenberg

Affiliations

  1. Department of Urology, University Hospital, LMU Munich, Munich, Germany.
  2. Department of Urology, University Hospital, LMU Munich, Munich, Germany. [email protected].
  3. Urologische Klinik und Poliklinik, Marchioninistr. 15, 81377, Munich, Germany. [email protected].

PMID: 33427927 PMCID: PMC8208936 DOI: 10.1007/s00210-020-02044-4

Abstract

Non-adrenergic prostate smooth muscle contractions may account for the limited effectiveness of α

Keywords: Benign prostatic hyperplasia (BPH); Lower urinary tract symptoms (LUTS); P2X; P2Y; Purinergic receptors; Smooth muscle contraction

References

  1. Mol Med Rep. 2012 Feb;5(2):313-6 - PubMed
  2. Br J Pharmacol. 2019 Dec;176 Suppl 1:S142-S228 - PubMed
  3. Am J Physiol Renal Physiol. 2013 Nov 15;305(10):F1383-90 - PubMed
  4. Br J Urol. 1976 Aug;48(4):255-63 - PubMed
  5. Neurourol Urodyn. 2014 Sep;33(7):1074-85 - PubMed
  6. Cochrane Database Syst Rev. 2018 Nov 16;11:CD010060 - PubMed
  7. J Ethnopharmacol. 2010 Jan 8;127(1):196-9 - PubMed
  8. Br J Pharmacol. 2003 Apr;138(7):1277-84 - PubMed
  9. Eur Urol. 2011 Mar;59(3):342-52 - PubMed
  10. Br J Pharmacol. 2006 Feb;147 Suppl 2:S88-119 - PubMed
  11. Differentiation. 2017 Jul - Aug;96:49-61 - PubMed
  12. Sci Rep. 2017 Apr 10;7(1):771 - PubMed
  13. Cardiovasc Res. 2005 May 1;66(2):345-52 - PubMed
  14. Auton Neurosci. 2016 Jan;194:8-16 - PubMed
  15. Eur J Pharmacol. 2018 Oct 15;837:45-52 - PubMed
  16. Eur J Pharmacol. 2004 Sep 24;499(3):335-44 - PubMed
  17. J Sex Med. 2012 Sep;9(9):2293-306 - PubMed
  18. Prostate. 2017 May;77(7):697-707 - PubMed
  19. Eur Urol. 2009 Apr;55(4):864-73 - PubMed
  20. Handb Exp Pharmacol. 2011;(202):485-526 - PubMed
  21. Eur J Pharmacol. 2020 Apr 15;873:172985 - PubMed
  22. Eur Urol. 2013 Jul;64(1):118-40 - PubMed
  23. Rev Urol. 2004;6 Suppl 9:S3-S10 - PubMed
  24. Eur Urol. 2007 Jun;51(6):1522-33 - PubMed
  25. Naunyn Schmiedebergs Arch Pharmacol. 2014 Nov;387(11):1017-23 - PubMed
  26. Eur J Pharmacol. 2015 Jul 5;758:24-30 - PubMed
  27. Neurourol Urodyn. 2015 Mar;34(3):292-8 - PubMed
  28. Eur Urol. 2017 Apr;71(4):570-581 - PubMed
  29. PLoS One. 2014 Sep 12;9(9):e107593 - PubMed
  30. Prostate. 2020 Aug;80(11):831-849 - PubMed
  31. Indian J Urol. 2014 Apr;30(2):181-8 - PubMed
  32. Naunyn Schmiedebergs Arch Pharmacol. 2020 Feb;393(2):243-251 - PubMed
  33. Urology. 2003 Jul;62(1):1-9 - PubMed
  34. Nat Rev Urol. 2013 Jan;10(1):49-54 - PubMed
  35. Naunyn Schmiedebergs Arch Pharmacol. 2020 May;393(5):829-842 - PubMed
  36. Br J Pharmacol. 2005 Feb;144(4):510-8 - PubMed
  37. Handb Exp Pharmacol. 2011;(202):117-48 - PubMed
  38. Front Physiol. 2018 Jun 15;9:734 - PubMed
  39. Br J Pharmacol. 2018 Jun;175(11):2077-2096 - PubMed
  40. Phytomedicine. 2010 Sep;17(11):895-901 - PubMed
  41. FASEB J. 2013 May;27(5):1895-903 - PubMed
  42. Neuropharmacology. 1999 Jan;38(1):141-9 - PubMed
  43. Br J Pharmacol. 2000 Nov;131(6):1073-80 - PubMed
  44. Br J Pharmacol. 2019 Dec;176 Suppl 1:S21-S141 - PubMed
  45. J Hypertens. 1990 Oct;8(10):897-908 - PubMed
  46. BMJ. 1994 Apr 9;308(6934):929-30 - PubMed
  47. Adv Pharmacol. 2011;61:333-72 - PubMed
  48. Curr Med Chem. 2015;22(7):851-65 - PubMed
  49. Urology. 2017 Aug;106:160-166 - PubMed
  50. Handb Exp Pharmacol. 2011;(202):527-42 - PubMed

Publication Types